Several other local government units (LGUs) in Metro Manila have already started vaccinating their senior citizens using CoronaVac, the COVID-19 vaccine of the Chinese pharmaceutical company Sinovac.
The government recently allowed the use of CoronaVac, the vaccine made by Sinovac, for senior citizens because it is said to be safe. There is also a shortage in the supply of AstraZeneca vaccines used for the elderly.
In Pasay City, apart from senior citizens, those with comorbidity or other diseases were also vaccinated this Monday using Sinovac vaccines.
This includes senior citizen Leticia Linsangan, who tested positive for COVID-19 in August.
“Natakot ako sa una noong magka-COVID kami. Nawalan kami ng pang-amoy 2 araw,” said Linsangan, who lined up at Juan Sumulong Elementary School to be vaccinated.
Giordano de Leon, a 59 -year -old dialysis patient, also got vaccinated.
“Proteksiyon lang, pero dapat ingat pa rin tayo. Face maks, face shield, tuloy-tuloy lang,” said De Leon.
In total, 14,938 have been vaccinated in Pasay City, including 5,112 with comorbidities.
Some LGUs begin vaccinating seniors with CoronaVac
Vaccination of seniors with Sinovac has also started in Quezon City and San Juan City.
In Quezon City, senior citizens often experience high blood pressure so their vaccinations are delayed, said doctors and nurses at vaccination sites.
It is said that the seniors wait for their blood pressure to calm down or drop before they are given the vaccine.
Vaccination of senior citizens in Caloocan and Malabon will also continue.
In Navotas, Mayor Toby Tiangco was also vaccinated against COVID-19 using CoronaVac at San Jose Academy.
In his statement, Tiangco called on other Navotas residents to register for the vaccination program.
There were 3,618 frontliners, senior citizens, and comorbidities when they were stabbed against COVID-19 in Navotas, Tiangco said.
Vaccination is on the rise despite a statement by the head of the China Centers for Disease Control that vaccines made in China do not have a high protection rate.
But according to Food and Drug Administration Director-General Eric Domingo, the Sinovac vaccine is 100 percent effective in severe cases of COVID-19.